MF

Marco Ferrara

BO BOE: 6 patents #223 of 3,149Top 8%
CT Centrexion Therapeutics: 1 patents #4 of 20Top 20%
Overall (2020): #18,037 of 565,922Top 4%
7
Patents 2020

Issued Patents 2020

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
10875867 Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide Christoph Hoenke, Barbara Bertani, Giacomo Fossati, Sara Frattini, Riccardo Giovannini +1 more 2020-12-29
10787432 N-[(pyridyloxy)propanyl]benzamides Doris Riether, Niklas Heine, Uta Friederike Lessel, Janet Rachel Nicholson, Anton Pekcec 2020-09-29
10738031 N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity Doris Riether, Niklas Heine, Uta Friederike Lessel, Janet Rachel Nicholson, Anton Pekcec 2020-08-11
10710984 N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides Doris Riether, Niklas Heine, Uta Friederike Lessel, Janet Rachel Nicholson, Anton Pekcec +1 more 2020-07-14
10675268 Somatostatin receptor subtype 4 (SSTR4) agonists Riccardo Giovannini, Yunhai Cui, Henri Doods, Stefan Just, Raimund Kuelzer +3 more 2020-06-09
10604511 N-[(pyrazinyloxy)propanyl]benzamides as antagonists of orexin subtype 1 receptor activity Doris Riether, Niklas Heine, Uta Friederike Lessel, Janet Rachel Nicholson, Anton Pekcec 2020-03-31
10577336 Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists Rocco Mazzaferro, Riccardo Giovannini, Iain Lingard, Klaus Rudolf 2020-03-03